Member Info for Mikey279

Why is a £300m mcap unrealistic?

If you are the leading CE diagnostic product globally and supply China, its game over...

Bit wild on the swings today..... but stay calm - CHINA are interested.

£5-£10 target

DYOR

288k of test quotations in the space 2 weekend days is no joke....

China was essentially the key to how far this can go.... as for RNS's this was probably the best i've seen in 5 years, up there with EUA's asset sale

look at the volume....

Not even joking when I say it could go to £5-£10+.... that RNS was pretty much confirmation that we're the leading diagnostic product

its individual tests but thats a £1m quotation in the space of two days....

Confirmed to be the first CE marked product

However, it is difficult to predict how demand for the test will grow as the epidemic is still in its early stages.

CE mark will help FDA application

The Primerdesign test is being formally evaluated by public health authorities from five countries and the Company is in discussions with these organisations to potentially support their national screening requirements for COVID-19.

Since the initial reports of COVID-19, the Company has invested in manufacturing capacity to meet the current and potential future demand for its tests.

As with our research use only test, it can produce a result in less than two hours, with the added efficiency of being able to transport the test at ambient temperatures eliminating the need for cold chain shipping. It is designed to run on multiple instrument platforms commonly used by clinical laboratories around the world, which ensures our COVID-19 test can be used by the largest possible number of clinicians.

It's just BOOMS all round......

Re-read it 5 times.... absolute stonker

Holy crap £5-£10 + could actually be a reality.....

Looks bloody good..... FIRST CE MARKED TEST AND 288,000 prelim quotations INCLUDING CHINA

Where are my folks from the weekend talking ****? Could've been 15% up already if you did your research.... but no, flu's a bigger killer

£5-£10+

DYOR

They don’t have a 7 eur target for no reason, have a feeling it can do a lot more though

All IMO

Don’t even need to say anything, this will only happen once in our lifetime (hopefully)... £5-£10 at some point.... let’s see

I actually think it has the potential to do 500%- 1000% + from here as we only have 60m shares in issue, it's a black swan event so cannot be compared to anything

DYOR though

You feel uncomfortable?...... you're doing more than the majority of the world supporting a company with a solution to the problem, even a simple tweet informing of the availability of a safe, accurate and quick diagnostic can potentially save many lives, without shareholder support Novacyt doesn't exist, put that into perspective

Looking at the speed they're moving and efforts to get necessary regulatory approvals it's clear they intend on being the dominant supplier of the COVID-19 diagnostics..... unlimited upside if they achieve this

This is entirely a one off event (hopefully), if you can't see the potential for this to head to £5-£10 +, you shouldn't really be investing in AIM

It's a complete different ball game from two weeks ago where we only had a few RUO kits

DYOR (a heads up - Don't look at the number of new cases/deaths being reported. Look at the infection rate, numbers in serious/critical condition and then look at the **** show in current diagnostic methods and Nova's competition)

Yep the Friday RNS was essentially the value trigger point.... you have to bare in mind that the majority of the rise in the past 2 weeks was based on only having an RUO product with 30k x (£4) sales

Now it's about to get REALLY interesting...

One thing for certain.... ALWAYS a good sign when the people looking for an entry appear